Pancreatic Cancer Research

ResearcherUniversità Campus Bio-MedicoActive in the last 2 years

Giuseppe Tonini

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4442-8677; OpenAlex author ID A5027983547, A5059367989. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. From Genomic Insight to Clinical Impact: Dramatic Response in RET Fusion-positive Pancreatic Cancer. Last author DOI 10.21873/anticanres.18417↗
  2. Prognostic and predictive factors in pancreatic cancer. Co-author DOI 10.18632/oncotarget.27518↗
  3. Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: A GISCAD randomized phase II study. Co-author DOI 10.1016/j.dld.2013.09.020↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bruno Vincenzi · 2 shared papers, 2020–2026 · strength 0.40
  2. Jessica Lucchetti · 1 shared paper, 2026 · strength 0.30
  3. Emanuela Dell’Aquila · 1 shared paper, 2020 · strength 0.10
  4. Daniele Santini · 1 shared paper, 2020 · strength 0.10
  5. Roberto Labianca · 1 shared paper, 2014 · strength 0.03
  6. Stefania Mosconi · 1 shared paper, 2014 · strength 0.03
  7. Francesco Di Costanzo · 1 shared paper, 2014 · strength 0.03
  8. Sandro Barni · 1 shared paper, 2014 · strength 0.03
  9. Rossana Berardi · 1 shared paper, 2014 · strength 0.03
  10. Luca Faloppi · 1 shared paper, 2014 · strength 0.03
  11. Michela Cinquini · 1 shared paper, 2014 · strength 0.03
  12. Stefano Cascinu · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.